q4 earnings per share $0.37.
sees fy revenue $6.25 billion to $6."4 billion.
compname reports q4 earnings per share $2.98.
reaffirms its previously issued three-year compound annual growth rate target for revenue to be in range of 4% to 6%.
q4 revenue $1.56 billion versus refinitiv ibes estimate of $1,521.7 million.
qtrly total revenue rose 12.2 percent to $6.2 billion.
compname reports q4 earnings per share $8.00.
q3 adjusted earnings per share $1.89 excluding items.
qtrly total revenue increased 7% to $7.8 billion.
q4 revenue rose 7.3 percent to $577 million.
q4 earnings per share $0.37.
q4 revenue $1,946 per patient day.
compname reports q4 2020 net income of $36 million, or $90 million, excluding items.
qtrly concentra segment adjusted ebitda includes $1 million in q4 and $35 million for full year 2021.
compname reports q4 interest income of $600 million.
sees capital expenditures for fiscal 2022 in range of $180 million to $200 million.
